Clinical Characteristics of Primary Liver Cancer

Launched by THE AFFILIATED NANJING DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL · Mar 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying primary liver cancer, a serious illness that affects the liver and is one of the most common types of cancer worldwide. The goal of the trial is to better understand the characteristics of this disease, including what causes it and how it develops. By identifying risk factors and learning more about how different patients respond to treatment, researchers hope to improve care and outcomes for people diagnosed with primary liver cancer.

To participate in this trial, you need to be at least 18 years old and have been newly diagnosed with primary liver cancer, confirmed through a special imaging test or a biopsy. Unfortunately, if you have other types of cancer or certain health conditions, like severe heart or lung issues, you may not be eligible. If you join the study, you can expect to undergo various assessments to help researchers gather important information about your condition. This trial is currently looking for participants, and it plays a crucial role in the fight against primary liver cancer, aiming to enhance understanding and treatment options for this challenging disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. 18 years or older;
• • 2. initial diagnosis of primary liver cancer based on enhanced CT or enhanced MRI or pathology
• Exclusion Criteria:
• • 1. other types of malignant tumors;
• • 2. mental illness, severe cardiopulmonary dysfunction, severe renal insufficiency, serious infection and cerebrovascular accident;
• • 3. received liver transplant or other organ transplant.